M.4 Non-Price Technical Evaluation Factors.pdf

PDF 125 KB Posted

Attached to
Equipment: 7T MRI System with a dedicated, high-performance, local gradient subsystem. Federal contract opportunity
Solicitation number
RFP-2026-NIH-7TMR
Issued by
Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development

About this file

This document presents the non-price technical evaluation factors and qualitative rating rubric for a 7T MRI system procurement by the National Institutes of Health (NIH). The evaluation will assess technical proposals based on six factors listed in strict order of relative importance: Technical Performance & Capability, Research Capability/Openness & Development Environment, Compatibility/Integration & Research Continuity, Turnkey Installation/Transition & Schedule, Relevant Experience & Technical Risk, and Training/Warranty/Service & Lifecycle Support.

The Technical Performance & Capability factor (Factor 1) emphasizes that the proposed 7T system must meet and beneficially exceed required performance specifications, particularly local gradient performance (≥200 mT/m, ≥900 T/m/s), RF performance, image quality, reconstruction performance, stability, homogeneity, and high-resolution/SMS/EPI capability, with evaluation credit awarded only for enhancements providing meaningful, demonstrable research benefits rather than merely higher numerical specifications. Factor 2 evaluates the quality and completeness of development environments, source-code availability, access to raw data, APIs/tools, ability to develop custom sequences and coils, vendor research support, and clear identification of restrictions or licensing dependencies. Factor 3 assesses compatibility with existing NIH MRI systems, protocols, data workflows, coils, and software, along with the ability to transition existing studies with minimal clinical disruption. Factor 4 addresses the technical soundness of site preparation, facility construction, installation, commissioning, and transition planning across an 18-to-24-month performance window while managing operational risks. Factor 5 evaluates demonstrated corporate and subcontractor experience delivering comparable human 7T systems with high-performance gradients, while Factor 6 assesses training quality, warranty coverage, field engineering support, software upgrades, parts availability, and long-term lifecycle support. The Technical Evaluation Panel will rate each factor using five consensus definitions: Outstanding (exceeds requirements with exceptional benefit and very low risk), Good (exceeds requirements meaningfully with low risk), Acceptable (meets mandatory requirements with acceptable risk), Marginal (has correctable weaknesses creating appreciable risk), and Unacceptable (fails material requirements or presents unacceptable risk).

View the file

Other files for this federal contract opportunity

Other files attached to Equipment: 7T MRI System with a dedicated, high-performance, local gradient subsystem., newest first.
File Type Posted
Amendment 0005 SF-30.pdf PDF
AMENDMENT 0005 SF-30 Continuation Sheet.pdf PDF
AMENDMENT 0004 SF-30.pdf PDF
Wage Determination NO. 2015-4269 Attachment 2.pdf PDF
Amendment 0003 SF-30 Continuation Sheets.pdf PDF
Amendment 0003 SF-30.pdf PDF
Amendment 0002 Block 14.pdf PDF
AMENDMENT 0001 DESCRIPTION OF MODIFICATIONS BLOCK 14 EQUIVALENT.pdf PDF
Amendment 00001 Questions and Answers Log.pdf PDF
B.1 CLIN Structure and B.2 Total Evaluated Price Calculation Formula.pdf PDF

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

M.4 Non-Price Technical Evaluation Factors

The technical proposal will be evaluated on compliance with providing the specified items and services outlined in the Section C Statement of Work (SOW). The evaluation factors below are listed in their strict order of relative importance.

Factor 1: Technical Performance & Capability Degree to which the proposed 7T system meets and beneficially exceeds required performance, particularly local gradient performance (≥200 mT/m, ≥900 T/m/s), RF performance, image quality, reconstruction performance, stability, homogeneity, and demonstrated high-resolution/SMS/EPI capability. Additional evaluation credit will be assigned only where an enhancement provides a meaningful, demonstrable research benefit to the NIH—not merely because a numerical specification is higher.

Factor 2: Research Capability, Openness & Development Environment Quality and completeness of pulse-sequence/reconstruction development environments; source-code availability; access to raw data; APIs/tools/documentation; ability to develop custom sequences, coils, and reconstruction methods; vendor research support; and the clear identification of any restrictions, licensing, or dependencies affecting baseline NIH research parameters.

Factor 3: Compatibility, Integration & Research Continuity Compatibility with existing NIH MRI systems, protocols, data workflows, coils, and software where applicable; networking interface architecture; researcher workflows; and the overall ability to transition existing studies and longitudinal protocols with minimal clinical disruption.

Factor 4: Turnkey Installation, Transition & Schedule Technical soundness and completeness of the site-preparation, facility construction, removal/trade-in extraction, installation, commissioning, testing, and transition plan; overall schedule credibility across the 18-to-24-month performance window; proactive management of operational risks; and the ability to avoid adversely affecting other active MRI systems in the facility at system handover.

Factor 5: Relevant Experience & Technical Risk Demonstrated successful corporate and subcontractor experience delivering comparable human 7T systems incorporating local high-performance gradients at or above the specified performance;

evidence that the proposed technology is mature, feasible, supportable, and technically sound within an active medical research center envelope.

Factor 6: Training, Warranty, Service & Lifecycle Support Quality of clinical applications and sequence development training; baseline and extended warranty coverage; field engineering response and support capabilities; software upgrades; parts availability matrices; system upgradeability; and the long-term ability to support the system throughout its anticipated research life.

M.5 Technical Qualitative Rating Rubric

The Technical Evaluation Panel (TEP) will evaluate each of the six factors above by mapping observed strengths, weaknesses, and risks directly to the following consensus definitions: Rating

Definition

Outstanding Exceeds requirements in multiple meaningful ways and provides exceptional benefit to NIH research goals; very low technical/performance risk.

Good Exceeds requirements in meaningful ways that provide an identifiable, beneficial asset to the facility; low technical risk.

Acceptable Meets all mandatory baseline requirements;

demonstrates no material strengths or deficiencies;

acceptable risk profile.

Marginal Has weaknesses or technical gaps that create appreciable performance risk but may be correctable through clarifications.

Unacceptable Fails to meet a material requirement or presents an unacceptable level of technical, physical, or performance risk

File details come from the government source that posted it. Updated .